Journal of medical Internet research
GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?
By Zucker A.
Abstract
GLP-1 medications are incredibly accessible-while this may be a net positive for eligible patients, their widespread marketing may not be. In this News and Perspectives article, JMIR Correspondent Anna Zucker reports on concerns being raised about the potential impact of GLP-1 marketing practices on body image and well-being.
Keywords
- Glucagon-Like Peptide 1
- Body Image
- Advertising
- GLP-1
- advertising
- body image
- digital health
- eating disorder
- glucagon-like peptide-1 receptor agonist
- mental health
- social media
- telehealth
Source
Published in Journal of medical Internet research. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.